Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on August 11, 2026

5 hours ago

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

Indeterminate GlobeNewswire

5 hours ago

 Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…

Indeterminate GlobeNewswire

5 hours ago

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Indeterminate GlobeNewswire

5 hours ago

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

5 hours ago

Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States

Indeterminate GlobeNewswire

6 hours ago

Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

6 hours ago

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth

Indeterminate GlobeNewswire

6 hours ago

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Indeterminate GlobeNewswire

6 hours ago

Constant Therapy Health Launches Web Platform for Speech, Language, and Cognitive Therapy

Indeterminate GlobeNewswire

6 hours ago

NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth

Indeterminate GlobeNewswire

6 hours ago

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

6 hours ago

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

Indeterminate GlobeNewswire

6 hours ago

Modern Haus Dental's Dr. Kristy Lee Recognized as Top Dentist by Bethesda Magazine for Third Consecutive Year

Indeterminate GlobeNewswire

6 hours ago

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

6 hours ago

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

Indeterminate GlobeNewswire

6 hours ago

Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer

Indeterminate GlobeNewswire

6 hours ago

Breckenridge Distillery Turns Colorado’s Famous Palisade Peaches into a Fresh Pour of Summer with New Peach Whiskey

Indeterminate GlobeNewswire

6 hours ago

Harvard Bioscience Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

6 hours ago

C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

6 hours ago

Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire